Sarah Cannon Research Institute LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Sarah Cannon Research Institute LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013186
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sarah Cannon Research Institute LLC (SCRI) is a research institute that offers integrated cancer services. The institute conducts clinical research programs for advancing cancer therapies. Its services include blood cancer network, cancer care overview, cardiovascular research, contract research organization, nurse navigators, oncology research, personalized medicine, radiation oncology, and site management organization. It offers early oncology drug development in both solid tumors and hematologic malignancies. SCRI conducts research in the fields of oncology and cardiology. The institute partners with investigators and pharmaceutical and biotech companies to conduct clinical trials. It has operations in Austin, Dallas, Denver, Kansa City, London, Nashville, North Florida, Richmond, and San Antonio, the US. SCRI is headquarters in Nashville, Tennessee, the US.

Sarah Cannon Research Institute LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Boehringer Ingelheim Expands Agreement with Sarah Cannon Research Institute 10
Eli Lilly Enters into Co-Development Agreement with Sarah Cannon Research Institute 11
Biocept Enters into Research Agreement with Sarah Cannon Research Institute 12
Sarah Cannon Research Institute And AstraZeneca Enter Into Agreement For Personalized Medicine 13
AstraZeneca Enters Into Co-Development Agreement With Sarah Cannon Research Institute 14
Acquisition 15
Sarah Cannon Research Institute to Acquire Genospace 15
Sarah Cannon Research Institute Acquires Clinical Development 16
Sarah Cannon Research Institute LLC – Key Competitors 17
Sarah Cannon Research Institute LLC – Key Employees 18
Sarah Cannon Research Institute LLC – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Government and Public Interest 21
Mar 28, 2016: OHC Provides Tri-State Patients with Access to Growing Number of Immunotherapy Clinical Trials 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Key Facts 2
Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sarah Cannon Research Institute LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Boehringer Ingelheim Expands Agreement with Sarah Cannon Research Institute 10
Eli Lilly Enters into Co-Development Agreement with Sarah Cannon Research Institute 11
Biocept Enters into Research Agreement with Sarah Cannon Research Institute 12
Sarah Cannon Research Institute And AstraZeneca Enter Into Agreement For Personalized Medicine 13
AstraZeneca Enters Into Co-Development Agreement With Sarah Cannon Research Institute 14
Sarah Cannon Research Institute to Acquire Genospace 15
Sarah Cannon Research Institute Acquires Clinical Development 16
Sarah Cannon Research Institute LLC, Key Competitors 17
Sarah Cannon Research Institute LLC, Key Employees 18
Sarah Cannon Research Institute LLC, Other Locations 20
Sarah Cannon Research Institute LLC, Subsidiaries 20

★海外企業調査レポート[Sarah Cannon Research Institute LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kvaerner ASA (KVAER):企業の財務・戦略的SWOT分析
    Kvaerner ASA (KVAER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • EyeGate Pharmaceuticals Inc (EYEG):企業の財務・戦略的SWOT分析
    Summary EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical and drug delivery company that develops and commercializes products for treating diseases and disorders of the eye. The company’s proprietary technology EyeGate II delivery system, utilizes transscleral iontop …
  • TECT Aerospace, Inc.:企業の戦略・SWOT・財務情報
    TECT Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report Summary TECT Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Arrowhead Pharmaceuticals Inc (ARWR):製薬・医療:M&Aディール及び事業提携情報
    Summary Arrowhead Pharmaceuticals Inc (Arrowhead), formerly Arrowhead Research Corp, is a pharmaceutical company that develops and markets medicinal products. The company develops pipeline drugs that are being developed to treat chronic hepatitis B virus infection for the treatment of liver disease, …
  • Cascade Metrix LLC:製品パイプライン分析
    Summary Cascade Metrix LLC (CMI) is a medical technology company that commercializes an automated POC blood analyzer for critical care. The company provides product portfolio such as novel micro-volume IV extension kits; and automated glucose monitoring systems, among others. It also provides a revo …
  • 84 Lumber Co:戦略・SWOT・企業財務分析
    84 Lumber Co - Strategy, SWOT and Corporate Finance Report Summary 84 Lumber Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Sri Lanka Telecom PLC (SLTL.N0000):企業の財務・戦略的SWOT分析
    Sri Lanka Telecom PLC (SLTL.N0000) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Kitov Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Kitov Pharmaceuticals Ltd (Kitov Pharmaceuticals) a subsidiary of Kitov Pharma Ltd, is a biopharmaceutical company with focus on drug development. Its pipeline therapeutic candidates include Consensi, a combination drug with celecoxib and amlodipine besylate as active ingredients for the tre …
  • Merck & Co Inc (MRK):企業の財務・戦略的SWOT分析
    Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Malaysian Resources Corporation Berhad (MRCB):企業の財務・戦略的SWOT分析
    Malaysian Resources Corporation Berhad (MRCB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Top Glove Corporation Berhad (TOPGLOV):医療機器:M&Aディール及び事業提携情報
    Summary Top Glove Corporation Berhad (Top Glove) is a manufacturer and distributor of rubber gloves. The company’s products include nitrile gloves, vinyl gloves, latex gloves, surgical gloves, clean room gloves, household gloves, polyisoprene gloves, and cast polyethylene gloves. It also provides th …
  • K2M Inc-医療機器分野:企業M&A・提携分析
    Summary K2M Inc (K2M), a subsidiary of K2M Group Holdings Inc is a medical device company that designs, develops and markets spine solutions products for the treatment of spinal pathologies. The company offers complex spine, minimally invasive, degenerative and biologics products. It offers complex …
  • Synthonics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Synthonics Inc (Synthonics) is a pharmaceutical company that discovers, develops and licenses metal coordinated pharmaceuticals. The company uses unique metal coordination chemistry for modifying specific properties of patent-expiring pharmaceuticals. It develops MCP-311, a drug candidate th …
  • Eli Lilly and Co (LLY)-製薬・医療分野:企業M&A・提携分析
    Summary Eli Lilly and Company (Lilly) is a healthcare company that discovers, develops and markets human and animal healthcare products. The company offers medicines for cardiovascular conditions, diabetes, cancer, neurological problems, critical care, men's health and musculoskeletal problems. It a …
  • REV Group Inc (REVG):企業の財務・戦略的SWOT分析
    REV Group Inc (REVG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Qiagen Marseille SA-製薬・医療分野:企業M&A・提携分析
    Summary Qiagen Marseille SA (HalioDx), formerly Ipsogen SA is a subsidiary of Qiagen NV, a drugs manufacturing company that develops and markets molecular diagnostic tests. The company offers products for the treatment of chronic myeloid, chronic lymphocytic, acute myeloid, and acute lymphoblastic l …
  • ULURU Inc (ULUR):医療機器:M&Aディール及び事業提携情報
    Summary ULURU Inc (ULURU) is a medical technology company that researches, develops, and markets wound care and muco-adhesive film products. The company’s products include Altrazeal and OraDisc. Its Altrazeal is a transforming powder dressing with Nanoflex technology for the management of exuding wo …
  • Clarins SA:企業の戦略・SWOT・財務情報
    Clarins SA - Strategy, SWOT and Corporate Finance Report Summary Clarins SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Zanders Paper GmbH:企業の戦略的SWOT分析
    Zanders Paper GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Arix Bioscience PLC:企業のM&A・事業提携・投資動向
    Arix Bioscience PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Arix Bioscience PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆